QTL |
GWAS Catalog Study |
Disease Trait |
Study Size |
Risk Allele |
Risk Allele Frequency |
P Value |
P Value MLOG |
Peak Marker |
Reported Odds Ratio or Beta-coefficient |
Ontology Accession |
PubMed |
GWAS559417_H |
GCST90102943 |
Dodecadienoate (12:2) (X-21343) levels |
8,809 European ancestry individuals |
A |
NR |
9E-47 |
46.046 |
rs151154986 |
0.593 |
dodecadienoate (12:2) measurement (EFO:0800572)
|
PMID:35050183 |
GWAS572661_H |
GCST90102896 |
Branched-chain, straight-chain, or cyclopropyl 12:1 fatty acid (X-22764) levels |
8,809 European ancestry individuals |
A |
NR |
4E-36 |
35.398 |
rs151154986 |
0.53 |
branched-chain, straight-chain, or cyclopropyl 12:1 fatty acid measurement (EFO:0800662)
|
PMID:35050183 |
GWAS674801_H |
GCST90200236 |
Undecenoylcarnitine (C11:1) levels |
8,253 European ancestry individuals |
A |
0.0297222 |
3E-28 |
27.523 |
rs151154986 |
0.48872 |
undecenoylcarnitine (C11:1) measurement (EFO:0800588)
|
PMID:36635386 |
GWAS675106_H |
GCST90200190 |
Dodecadienoate (12:2) levels |
8,244 European ancestry individuals |
A |
0.0295118 |
1E-43 |
43 |
rs151154986 |
0.604805 |
dodecadienoate (12:2) measurement (EFO:0800572)
|
PMID:36635386 |
GWAS675402_H |
GCST90200249 |
Branched-chain, straight-chain, or cyclopropyl 12:1 fatty acid levels |
8,256 European ancestry individuals |
A |
0.029344 |
5E-28 |
27.302 |
rs151154986 |
0.479922 |
branched-chain, straight-chain, or cyclopropyl 12:1 fatty acid measurement (EFO:0800662)
|
PMID:36635386 |
GWAS712317_H |
GCST90264879 |
Plasma branched-chain, straight-chain, or cyclopropyl 12:1 fatty acid* levels in chronic kidney disease |
4,945 European ancestry individuals |
A |
0.03 |
1E-16 |
16 |
rs151154986 |
0.537 |
branched-chain, straight-chain, or cyclopropyl 12:1 fatty acid measurement (EFO:0800662)
|
PMID:37277652 |
GWAS714406_H |
GCST90265054 |
Plasma dodecadienoate (12:2)* levels in chronic kidney disease |
4,960 European ancestry individuals |
A |
0.03 |
6E-23 |
22.222 |
rs151154986 |
0.453 |
dodecadienoate (12:2) measurement (EFO:0800572)
|
PMID:37277652 |
GWAS717023_H |
GCST90245707 |
X-22764 levels |
14,296 European ancestry individuals |
A |
0.0311 |
2E-61 |
60.699 |
rs151154986 |
0.47113824 |
metabolite measurement (EFO:0004725)
|
PMID:36357675 |
GWAS742902_H |
GCST90245668 |
X-21343 levels |
14,296 European ancestry individuals |
A |
0.0314 |
4E-64 |
63.398 |
rs151154986 |
0.47785544 |
metabolite measurement (EFO:0004725)
|
PMID:36357675 |
GWAS742979_H |
GCST90200263 |
(2 or 3)-decenoate (10:1n7 or n8) levels |
8,124 European ancestry individuals |
A |
0.0293248 |
7E-15 |
14.155 |
rs151154986 |
0.345378 |
(2 or 3)-decenoate (10:1n7 or n8) measurement (EFO:0800594)
|
PMID:36635386 |
GWAS961344_H |
GCST90140296 |
Branched-chain, straight-chain, or cyclopropyl 12:1 fatty acid levels |
6,136 Finnish ancestry individuals |
A |
NR |
2E-17 |
16.699 |
rs151154986 |
0.88 |
branched-chain, straight-chain, or cyclopropyl 12:1 fatty acid measurement (EFO:0800662)
|
PMID:35347128 |
GWAS962673_H |
GCST90140169 |
(2 or 3)-decenoate (10:1n7 or n8) levels |
6,136 Finnish ancestry individuals |
A |
NR |
6E-11 |
10.222 |
rs151154986 |
0.68 |
(2 or 3)-decenoate (10:1n7 or n8) measurement (EFO:0800594)
|
PMID:35347128 |
GWAS963708_H |
GCST90140147 |
Dodecadienoate (12:2) levels |
6,136 Finnish ancestry individuals |
A |
NR |
1E-24 |
24 |
rs151154986 |
1.06 |
dodecadienoate (12:2) measurement (EFO:0800572)
|
PMID:35347128 |